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Abstract
Background: Respiratory syncytial virus (RSV) infection of airway epithelial cells stimulates the
expression and secretion of a variety of cytokines including the chemotactic cytokines interleukin-
8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation,
normal T cell expressed and secreted). Chemokines are important chemoattractants for the
recruitment of distinct sets of leukocytes to airway sites of inflammation.
Results: We have shown previously that chemokine expression is regulated in airway epithelial
cells (A549) in a stimulus-specific manner in part through the redox-responsive transcription
factors AP-1 and NF-κ B. In this study, we examined the NF-κ B-mediated effects of RSV and the
proinflammatory cytokine TNFα  on the induction of IL-8, MCP-1 and RANTES chemokine gene
expression in A549 epithelial cells. The results demonstrate that RSV induces chemokine
expression with distinct kinetics that is associated with a specific pattern of NF-κ B binding activity.
This distinction was further demonstrated by the differential effects of the NF-κ B inhibitors
dexamethasone (DEX) and N-acetyl-L-cysteine (NAC). NAC preferentially inhibited RSV induced
chemokine expression, whereas DEX preferentially inhibited TNFα  induced chemokine
expression. DNA binding studies using NF-κ B subunit specific binding ELISA demonstrated that
RSV and TNFα  induced different NF-κ B binding complexes containing Rel A (p65) and NF-κ B1
(p50). Both TNFα  and RSV strongly induced Rel A the activation subunit of NF-κ B, whereas only
TNFα  was able to substantially induce the p50 subunit. Consistent with the expression studies, RSV
but not TNFα  induction of Rel A and p50 were markedly inhibited by NAC, providing a mechanism
by which TNFα  and RSV can differentially activate chemokine gene expression via NF-κ B.
Conclusions: These data suggest that RSV induction of chemokine gene expression, in contrast
to TNFα , involves redox-sensitive NF-κ B complexes containing predominantly Rel A.
Background
Respiratory syncytial virus (RSV) belongs to the Pneumo-
virinae subfamily of the Paramyxovirodae family of envel-
oped single-stranded negative sense RNA viruses. RSV
infection of the lower respiratory tract cells results in cell
death and sloughing into the lumen of the respiratory
tree. Worldwide, RSV is the leading cause of infant mortal-
ity from respiratory infections and is so highly contagious
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that by age two nearly all children have been infected. RSV
infection in infancy cause severe bronchiolitis and pneu-
monia and may predispose children to the subsequent de-
velopment of asthma, the most common chronic illness
of childhood [1]. Many studies have indicated that chem-
okines can play an important role in the onset and severity
of asthma and it has been shown that RSV infection of
lung epithelial cells increases chemokine production, al-
though the mechanisms involved are largely unknown
[2–5].
The chemotactic cytokines, or chemokines, compose a
large superfamily of small structurally related polypep-
tides that play important roles in host defense by recruit-
ing specific subsets of leukocytes to sites of inflammation
and injury [6]. Chemokines have been associated with a
number of inflammatory diseases and conditions, includ-
ing asthma, sepsis, inflammatory bowel disease, and adult
respiratory distress syndrome [7–9]. The chemokine su-
perfamily can be divided into two major groups based on
the position of the first two of four-conserved cysteine res-
idues at the amino terminus, which are either adjacent
(CC subfamily) or separated by one amino acid (CXC
subfamily). The CXC chemokines such as IL-8 were origi-
nally identified as potent activators and chemoattractants
for neutrophils, whereas the CC chemokines such as
MCP-1 and RANTES mostly attract monocytes and eosi-
nophils respectively [10]. Chemokines are secreted in a
stimulus-and cell type-specific manner [11–17] and are
regulated primarily at the level of gene transcription [18–
24]. The transcriptional promoters of IL-8, RANTES and
MCP-1 contain binding sites for the redox-responsive
transcription factor NF-κ B, which has been shown to be
important for their regulation by viral infections and cy-
tokines [18,20,23,25–34].
We previously demonstrated that the chemokines IL-8,
MCP-1 and RANTES are differentially regulated in A549
airway epithelial cells [35–38]. To further elucidate the
mechanisms of chemokine expression in A549, we have
compared the induction of IL-8, MCP-1 and RANTES by
RSV infection with that of TNFα . Our findings suggest that
RSV induction of chemokine gene expression involves a
redox-sensitive NF-κ B signaling mechanism that differs
from that mediated by TNFα  and involving predominant-
ly the Rel A subunit of NF-κ B.
Materials and methods
Materials
Dulbecco's Modified Eagle Medium (DMEM), fetal bo-
vine serum (FBS), Dulbecco's phosphate buffered saline
(DPBS), antibiotic/antimycotic, 1% trypsin/EDTA, Hanks
Balanced Salt Solution (HBSS) and TRIZOL were pur-
chased from Invitrogen Gibco Cell Culture (Carlsbad,
CA). N-acetyl-L-cysteine, dexamethasone, glycerol and
MTT tetrazolium salt were obtained from Sigma (St. Lou-
is, MO). TNFα  was obtained from R&D systems (Minne-
apolis, MN). ELISA kits were purchased from Pierce
Endogen (Rockford, IL). Human CK5 RiboQuant ribonu-
clease protection assay kit was purchased from BD
Pharmingen (San Diego, CA). [α -32P]UTP (250 µCi) was
obtained from Perkin Elmer Life Sciences (Boston, MA).
Gel shift assay system was purchased from Promega
(Madison, WI). [γ -32P]ATP (500 µCi) was obtained from
ICN (Costa Mesa, CA). Antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The A549 cell
line and RSV Long strain were obtained from the Ameri-
can Type Culture Collection (Rockville, MD).
Virus stock growth and maintenance
RSV, Long strain, was grown on HEp-2, a human tracheal
epithelial cell line. Cells were grown to 50% confluence in
DMEM containing 7% FBS and 1% antibiotic/antimy-
cotic. After two washes with 1X DPBS, a minimal volume
of RSV, at a multiplicity of infection (MOI) of 1 or greater,
containing less than 1% FBS was added. The virus and
cells were incubated for 2 hours, after which DMEM was
added to bring culture to normal growth volume and 7%
FBS. Cultures were then incubated for 48 hours. All plates
were scraped and contents were transferred to 50 ml con-
ical tubes. The virus/cell cocktail was vortexed briefly and
large debris was removed in a tabletop centrifuge. RSV was
purified by ultracentrifugation through 30% glycerol in
HBSS. RSV stocks were resuspended in HBSS containing
0.5% bovine serum albumin and 100 mM magnesium
sulfate and frozen at -70° C.
Cell culture, infection and treatments
The A549 human type II lung carcinoma cell line was
grown and maintained in DMEM containing 7% FBS and
1% antibiotic/antimycotic. For treatment, cells were
grown to approximately 75% confluence, washed once
with 1X DPBS and incubated overnight with DMEM con-
taining 1% FBS. Cultures were then washed twice with 1X
DPBS and pretreated with inhibitors DEX or NAC in se-
rum-free DMEM to final concentrations as indicated in
the figures. RSV and TNFα  were added to the DMEM/in-
hibitor mix to final concentrations as indicated in the fig-
ures. One hour after agonist addition, FBS was added to
1% concentration for the duration of the experiment.
Protein secretion
After addition of RSV and TNFα , cells were cultured for 24
h. Supernatants were collected and spun at high speed to
remove cellular debris. The resulting suspension was fro-
zen at -70°C until assayed following manufacturer's in-
structions by chemokine-specific ELISA (Endogen).BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/5
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RNase protection
RNase protection assays (RPA) were performed using an
RPA kit purchased from BD Pharmingen. In brief, total
RNA was isolated from stimulated A549 cells with TRI-
ZOL. The hCK-5 multiprobe template set was used to syn-
thesize RNA probes for the chemokines lymphotactin,
RANTES, IP-10, MIP-1α , MIP-1β , IL-8, MCP-1, and I-309
as well as the house-keeping genes L32 and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) labeled with
[α -32P]UTP using T7 RNA polymerase. 3 ×  105 cpm of la-
beled probe were hybridized with 10 µg of total RNA for
16 h at 56°C. MRNA-probe hybrids were treated with
RNase cocktail and phenol-chloroform extracted. Protect-
ed hybrids were resolved on a 6% denaturing polyacryla-
mide sequencing gels and exposed to a Molecular
Dynamics detection screen overnight. Laser densitometry
was performed using a Molecular Dynamics Storm scan-
ner system (Molecular Dynamics, Inc., Sunny vale, CA).
DNA binding studies
Electrophoretic mobility shift assays (EMSA) were per-
formed essentially as described previously [39]. Briefly,
nuclear protein extracts (7 µg protein) prepared form
A549 cells by the method of Osborn et al[40] were incu-
bated with 5 ×  105 cpm (~0.1 ng) of 32P end-labeled con-
sensus NF-κ B oligonucleotide (5'-
AGTTGAGGGGACTTTCCCAGGC-3') probe contained in
the Promega gel shift assay system for 20–30 min at room
temperature in 10 µl reaction volume using the kit provid-
ed reaction buffer. To demonstrate binding specificity,
100-fold molar excess (10 ng) of a specific or non-specific
oligonucleotide (5'-ATTCGATCGGGGCGGGGCGAGC-
3') was included in the binding reaction. Protein-DNA
and protein-DNA-antibody complexes were resolved in
5% polyacrylamide gels preelectrophoresed for 30 min at
room temperature in 0.25X TBE buffer (22.5 mM Tris-bo-
rate and 0.5 mM EDTA, pH 8.3). Gels were dried and ex-
posed to radiographic film with an intensifying screen at -
70°C.
NF-kappaB subunit specific ELISA
NF-κ B subunits Rel A (p65) and NF-κ B1 (p50) were quan-
tified using Trans-AM™ transcription factor assay kit from
Active Motif (Carlsbad, CA). The assay is essentially an
ELISA in which the consensus NF-κ B binding site (5'-
GGGACTTTCC-3') is immobilized onto the 96 well plate.
Nuclear cell extracts (3 µg) were added to the wells and as-
sayed for either Rel A or p50 binding as per the manufac-
turer's instructions. Optical density was determined on a
spectophotometer at 450 nm.
Results
RSV induction of chemokine expression differs from that 
induced by TNFalpha
As shown in Fig. 1, RSV infection of A549 epithelial cells
induces the production and secretion of the chemokines
IL-8, MCP-1, and RANTES. In A549 epithelial cells sub-
stantial MCP-1 was constitutively expressed whereas little
or no spontaneous IL-8 or RANTES was detected. Howev-
er, upon RSV infection (MOI = 3) a significant increase in
chemokine production and secretion was observed 24 hr
post-infection for each of the chemokines.
To determine whether the chemokine induction was me-
diated by increased chemokine gene expression we as-
sessed the kinetics of mRNA synthesis by chemokine
specific RNase protection. A549 cells were infected with
RSV (MOI = 1) or stimulated with TNFα  (100 ng/ml) and
total RNA isolated at various times post-treatment over a
24 hr time course. As shown in Fig. 2, RSV rapidly induced
IL-8 and MCP-1 with steady-state mRNA readily detected
as early as 1 hr and continued to increase over the 24 hr
time course. In contrast, RANTES mRNA was not detected
until 4 hrs post infection after which its expression rapidly
increased also reaching a maximum at 24 hrs. The RSV in-
duction kinetics differed dramatically from the induction
kinetics for TNFα  in the same experiment. Whereas RSV
induction of the chemokines did not reach a maximum
until 24 hrs, TNFα  induction was maximal between 4 and
8 hrs and was either unchanged or lower at 24 hrs post-in-
fection.
Figure 1
RSV induces chemokine protein secretion from A549
cells. 2 ×  105 A549 cells were infected by RSV (MOI = 3) for
24 hr and supernatants assessed for IL-8, MCP-1 and
RANTES by chemokine specific ELISA. The histogram shows
the mean pg/ml of protein detected from three independent
experiments. The error bars show the standard deviation
from the mean.
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The magnitude of induction also differed between TNFα
and RSV infection. In general TNFα  was a stronger inducer
of chemokine expression. This difference was also reflect-
ed in the amount of chemokine secreted from the cells
(data not shown). Together, these data indicate that RSV
infection of A549 epithelial cells induces chemokine ex-
pression with distinct kinetics suggesting the mechanism
of RSV induction differs from that of proinflammatory cy-
tokines.
NF-kappaB inhibitors differentially effect RSV and TNFal-
pha induction of chemokine expression
IL-8, MCP-1 and RANTES gene expression are regulated by
the redox responsive transcription factor NF-κ B
[18,20,23,25–33,41–44]. The NF-κ B signaling pathways
have been shown to be differentially affected by antioxi-
dants and glucocorticoid steroids [45]. To determine
whether RSV and TNFα  induction of chemokine expres-
sion might be mediated by different NF-κ B signaling path-
ways we pretreated A549 cells with the glutathione
precursor N-acetyl-L-cysteine (NAC) or the synthetic glu-
cocorticoid dexamethasone (DEX). Twenty-four hours
post infection, total RNA was isolated and steady state
mRNA expression analyzed by chemokine specific RNase
protection. As shown in Fig. 3, the two inhibitors had very
different effects on chemokine gene expression. Most
strikingly, RSV induced chemokine expression was more
sensitive to NAC, whereas TNFα  induced chemokine ex-
pression was conversely more sensitive to DEX. Thus,
NAC preferentially inhibited chemokine expression in-
duced by RSV, while DEX predominantly inhibited chem-
okine expression induced by TNFα .
Differential inhibition of TNFalpha and RSV induced NF-
kappaB
NF-κ B binds to the chemokine promoter as either homo-
or heterodimers composed of Rel A (p65) and NF-κ B1
(p50). Initially we detected TNFα  and RSV induction of
NF-κ B by EMSA (KA Roebuck and LR Carpenter unpub-
lished data) but because multiple gel shift complexes were
induced it was not possible to distinguish the individual
contributions of Rel A and p50 to the formation of these
complexes. Therefore to assess the induction of the Rel A
and p50 subunits individually in A549 nuclear cell ex-
tracts, we used a subunit specific NF-κ B binding ELISA sys-
tem that utilizes anti-Rel A and anti-p50 antibodies. As
shown in Fig. 4, Rel A and p50 subunits of NF-κ B are dif-
ferentially expressed and induced in A549 epithelial cells.
In untreated cells, no Rel A (solid bars) was detectable
whereas in resting cells constitutive levels of p50 were ob-
served (open bars), suggesting that unstimulated A549 ep-
ithelial cells contain p50 homodimers, which with regard
to transcriptional activity have been shown to be func-
tionally inert or inhibitory. In contrast, cells stimulated by
TNFα  (Fig. 4A) or infected by RSV (Fig. 4B) markedly in-
duced Rel A, the transcriptionally active subunit of NF-κ B.
In addition, TNFα  was also able to induce p50 by about 5-
fold whereas RSV increased the constitutive p50 level by
only about 50%. The induction of Rel A and p50 were spe-
cific since competition with either wild type or mutant
consensus NF-κ B oligonucleotide respectively inhibited
Figure 2
Chemokine mRNA expression induced by RSV and
TNFα . 2 ×  107 A549 cells were either infected by RSV (MOI
= 1) or stimulated with 100 ng/ml TNF-α . Total RNA was
isolated at 1,2, 4, 8, and 24 h and assessed for chemokine
expression by RNase protection. Chemokine expression was
quantified by densitometry as described in the Methods. The
graphs show the time course of chemokine mRNA after nor-
malizing to GAPDH (lowest band in the gel). Shown is repre-
sentative of 3 independent experiments.
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or not the RSV and TNFα  induced binding activity. These
data demonstrate that TNFα  is a potent inducer of both
Rel A and p50 whereas RSV primarily induces the Rel A
subunit of NF-κ B.
To determine whether RSV and TNFα  activate NF-κ B dif-
ferently, we examined the effects of NAC and DEX on Rel
A and p50 binding activity. As shown in Fig. 4, Rel A and
p50 subunits are differentially inhibited by NAC and DEX
which have been shown to inhibit NF-κ B by distinct
Figure 3
Chemokine mRNA inhibition in A549 cells. 2 ×  107
A549 cells were pretreated with 5 mM N-acetyl-L-cysteine
(NAC) or 500 nM dexamethasone (DEX). After 1 hr the pre-
treated cells were either infected with RSV (MOI = 1) or
stimulated with TNFα  (100 ng/ml) for 24 hr. The graphs
show the percent inhibition for each chemokine mRNA after
normalization to GAPDH. Shown is representative of two
independent experiments.
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Figure 4
Induction of Rel A (p65) and NF-κ B1 (p50) by RSV
and TNFα  is differentially inhibited by NAC and
DEX. 2 ×  107 A549 cells were pretreated with 5 mM N-
acetyl-L-cysteine (NAC) or 500 nM dexamethasone (DEX).
After 1 hr the pretreated cells were either stimulated with
TNFα  (100 ng/ml) or infected with RSV (MOI = 1) for 2 hr.
Nuclear extracts (3 µg) were prepared and assessed for Rel
A (p65, solid bars) or NF-κ B1 (p50, open bars) binding activ-
ity using a Trans-AM™ transcription factor assay kit from
Active Motif (Carlsbad, CA) as per the manufacturer's
instructions. Graph shows the NF-κ B activation results
(OD450nm) from A549 cells stimulated with TNFα  (A) or
infected with RSV (B). An excess of either wildtype (wt) or
mutant (mut) NF-κ B oligonucleotide provided by the kit was
included in the binding reactions to demonstrate NF-κ B
binding specificity. Note that NAC and DEX inhibits RSV
induced p65 and p50 whereas the inhibitors had no effect on
TNFα  induced NF-κ B binding activity.
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mechanisms. Both NAC and DEX were unable to inhibit
TNFα  induction of either Rel A or p50. In contrast, in RSV
infected cells both DEX and NAC inhibited Rel A and p50
binding activity. However, the inhibitory effects were
most striking for Rel A suggesting the inhibitors primarily
target the RSV induction of Rel A.
The differential effects of NAC on TNFα  and RSV induced
NF-κ B binding activity correlated with its effects on chem-
okine gene expression (Fig. 3) and protein secretion (data
not shown) suggesting that RSV induces IL-8, MCP-1 and
RANTES through redox-sensitive NF-κ B binding complex-
es. DEX also showed differential effects on NF-κ B binding
activity with DEX preferentially inhibiting RSV induction
of NF-κ B. However, the effects of DEX on NF-κ B binding
induced by TNFα  did not correlate with its effects on
chemokine expression, suggesting in TNFα  activation of
chemokine gene expression DEX targets another mecha-
nism of chemokine induction not involving NF-κ B.
Discussion
In this study, we examined the role of NF-κ B in the activa-
tion of chemokine gene expression in response to TNFα
and RSV infection. The inhibitor studies correlating chem-
okine gene expression and NF-κ B binding activity indicate
that RSV, in contrast to TNFα , induces IL-8, MCP-1 and
RANTES expression in A549 epithelial cells through a re-
dox-sensitive NF-κ B signaling pathway that appears to in-
volve predominately Rel A. IL-8, MCP-1 and RANTES are
known redox regulated genes and our results are consist-
ent with the findings that oxidant tone can regulate chem-
okine gene expression in RSV infected airway epithelial
cells [46–48].
NF-κ B activation is controlled by its inhibitory protein I-
κ Bα  which when phosphorylated on ser32 and ser36
marks it for degradation by the 26S proteosome complex.
Thus I-κ B is a potential regulatory target for the differen-
tial induction of NF-κ B. Although we have not directly ex-
amined the role of I-κ B, Fiedler et al[49,50] have reported
differential effects of RSV and TNFα  on I-κ B activity in
A549 epithelial cells. In addition, Bitko and Barik [51]
have demonstrated that another I-κ B protein (I-κ Bβ ) may
also contribute via a redox-sensitive pathway to NF-κ B ac-
tivation by RSV.
In addition to NF-κ B dependent regulation there appears
to also be NF-κ B independent activation of chemokine ex-
pression since DEX inhibited TNFα  induced chemokine
expression but not NF-κ B binding activity. Along these
lines, it has been shown that RSV activation of chemokine
gene promoters involves multiple inducible transcription
factors including AP-1 [52,53], which is also a redox sen-
sitive transcription factor important in chemokine gene
expression [28,36,54]. AP-1 can also be inhibited by DEX
and has been shown to cooperate with NF-κ B to mediate
RSV induction of IL-8 [46,55].
The differential effects of NAC and DEX on chemokine
gene expression and NF-κ B activation suggest that the
mechanisms of RSV and TNFα  activation of NF-κ B and
chemokine expression differ possibly involving distinct
NF-κ B signaling mechanisms. TNFα  rapidly and potently
activates Rel A and p50 subunits of NF-κ B through a ki-
nase-mediated phosphorylation cascade involving a high
molecular mass signaling complex called the IKK complex
[56]. TNFα  activation of the multiprotein IKK complex re-
sults in the serine phorsphorylation of I-κ B and the subse-
quent activation of NF-κ B [57].
Consistent with the idea of RSV and TNFα  activating dis-
tinct NF-κ B signaling pathways, we found that the NF-κ B
inhibitor NAC had differential effects on chemokine gene
expression. In contrast to TNFα , RSV induced chemokine
expression was sensitive to NAC particularly the Rel A
(p65) subunit. NAC is an antioxidant thiol that raises the
intracellular pool of glutathione the major redox regulat-
ing mechanism in the A549 epithelial cell line [45]. Inter-
estingly, it has been reported that NAC can have
differential effects on NF-κ B binding activity suggesting
only a subset of NF-κ B binding complexes are redox sen-
sitive [58]. Moreover, it has been shown that NAC inhibits
Rel A/p50 heterodimers but not p50 homodimers and can
inhibit NF-κ B binding to only certain variant κ B elements
which presumably interact with distinct redox sensitive
NF-κ B binding complexes [59]. These observations are
consistent with our findings that indicate NAC predomi-
nantly inhibits Rel A homodimers since that was the ma-
jor NF-κ B subunit induced by RSV infection of A549 cells.
Consistent with RSV and TNFα  inducing functionally dis-
tinct NF-κ B binding complexes, AP-1 was recently shown
to be the preferential cooperative partner with NF-κ B in
RSV-induced IL-8 expression [46], whereas in TNFα -in-
duced expression NF-κ B cooperates preferentially with
NF-IL-6 [18,19,22]. Apparently, the stimulus-specific gene
regulation of chemokines is complex involving differen-
tial cooperativity of redox sensitive and redox resistant
NF-κ B complexes with other transcription factors to form
unique higher order transcription complexes.
Conclusions
Taken together, our data indicate that RSV, in contrast to
the cytokine TNFα , activate NF-κ B and chemokine gene
expression through a redox sensitive NF-κ B signaling
pathway involving predominately Rel A.
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